Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Experts Find Flaws In Diet Pill Study

Jul 23, 2003 | UPI

Questions are being raised about a medical study by manufacturers on the safety of ephedra diet pills, a report said Wednesday.

Documents released Tuesday by a House subcommittee show a panel of scientists has found flaws and shortcomings in the data. Some government officials said those problems could undercut its safety findings at a time when federal regulators are trying to decide if they should ban ephedra, an herbal stimulant, or restrict its sales, the New York Times reported.

For several years, the industry had refused to give the regulators all the data from the study, which was conducted at medical centers in New York and Boston in the late 1990s.

But last February, the Food and Drug Administration made an unusual deal to gain access to the data, officials say.

The agency had to make the deal because drug companies are required to prove the safety of their products and must turn over safety data and consumer complaints to the FDA. The agency, under a 1994 law, has no such authority over the makers of dietary supplements like ephedra.


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo